Tag: ACC 2021index/list_11902_10

Novel IL-6 Antibody Slashes CRP up to 92% in High-risk ASCVD

HOLIDAY Monitors: Even One Drink Doubles Risk for AF Within 4 Hours

Early Aspirin Withdrawal After PCI: More Benefit for Women?

ACC Survey: COVID Slams Already Weary CV Workforce

New Approach to Heart Failure Targets Myocardial Fibrosis

FIDELIO-DKD: Finerenone Cuts New-Onset AFib in Patients With Type 2 Diabetes and CKD

Sotagliflozin’s HFpEF Benefit Confirmed by New Analyses

RAFT-AF, Despite Itself, Hints at Advantage for Ablation Rhythm Control in Heart Failure With AF

Dapagliflozin Misses as Treatment for COVID-19 but Leaves Intriguing Signal for Benefit